Financing ·
Smith & Nephew plc applied to the London Stock Exchange for the block admission of 150,000 ordinary shares, each with…
SNNSmith & Nephew PLC
Smith & Nephew plc applied to the London Stock Exchange for the block admission of 150,000 ordinary shares, each with a nominal value of US20 ¢. These shares are being issued to settle awards under the company's employee share plans and are expected to begin trading on 6 July 2026. The new shares will rank pari passu with existing ordinary shares. Smith & Nephew plc is a medical technology company that develops and manufactures advanced medical devices.